A new UK government study has reportedly found that two doses from either the Oxford/AstraZeneca or the Pfizer vaccine are over 80 per cent effective in preventing infection from the B1.617.2 variant of Covid-19, first discovered in India.
The UK findings are said to be based on data from Public Health England and have also revealed that the two doses provide 87 per cent protection from the B.117 variant, first discovered in Kent region of England and also considered highly transmissible.
According to ‘The Telegraph’ newspaper, the latest study's findings were presented to a meeting of the government’s New and Emerging Respiratory Virus Threats Advisory Group (Nervtag) this week.